Vivoryon Therapeutics N.V. (AMS:VVY)
1.340
-0.020 (-1.47%)
Apr 16, 2026, 5:35 PM CET
Vivoryon Therapeutics Market Cap
Vivoryon Therapeutics has a market cap or net worth of €40.28 million as of April 16, 2026. Its market cap has decreased by -16.03% in one year.
Market Cap
40.28M
Enterprise Value
35.51M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
€1.34
Market Cap Chart
Since October 27, 2014, Vivoryon Therapeutics's market cap has decreased from 135.32M to 40.28M, a decrease of -70.24%. That is a compound annual growth rate of -10.02%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 15, 2026 | 40.28M | -4.23% |
| Dec 31, 2025 | 42.05M | -18.93% |
| Dec 31, 2024 | 51.87M | -75.55% |
| Dec 29, 2023 | 212.18M | -14.71% |
| Dec 30, 2022 | 248.77M | -34.60% |
| Dec 31, 2021 | 380.39M | 111.35% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Holland Colours | 75.71M |
| Value8 | 62.43M |
| Global InterConnection Group | 60.19M |
| BM3EAC | 53.39M |
| Morefield Group | 48.67M |
| New Amsterdam Invest | 46.91M |
| Cabka | 45.96M |
| Bever Holding NV | 42.64M |